READ: CDC - Bacterial Agents Part Two
/
READ: CDC - Bacterial Agents Part One
/
(4 RC) - The uncertainty and change regarding the identification of emerging bacterial agents and the requirements for containment and safe storage of pathogens continues to accelerate. New infectious agents and diseases have emerged. Work with infectious agents in public and private research, public health, clinical and diagnostic laboratories, and in animal care facilities has expanded… (Biosafety in Microbiological and Biomedical Laboratories, Jun 2020)
Read MoreREAD: Proposed Guidance for COVID-19 Pneumonia Respiratory Follow-up
/
(1/2 RC) - This guidance is intended to be pragmatic but sufficiently detailed to allow timely identification of patients experiencing persistent or evolving respiratory complications of COVID-19. Where possible this guidance suggests virtual solutions at relevant points along the patient pathway with the goal of mitigating … (British Thoracic Society, May 2020)
Read MoreREAD: NHS (UK) Clinical Guidance for post-COVID syndrome
/
(2 RC) - The purpose of this document is to provide commissioning guidance on the development of a specification to assist local healthcare systems to establish post-COVID assessment clinics for patients experiencing long-term health effects following COVID-19 infection. Clinics will offer physical, cognitive and psychological assessments with the aim of providing consistent … (NHS, Nov. 2020)
Read MoreREAD: NHS (UK) Clinical Management for suspected COVID-19 infection
/
(1 RC) - This guidance is for clinicians caring for adults and children admitted to hospital with suspected COVID-19 infection. It does not replace clinical judgement or specialist consultation. COVID-19 infection may present with mild, moderate or severe illness; the latter includes severe pneumonia, acute respiratory distress syndrome (ARDS), sepsis and septic shock. Early recognition of suspected patients… (NHS, Jan. 2020)
Read MoreREAD: COVID-19 Proposed Guidelines for patients with COPD
/
(1 RC) - The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals and practitioners are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients … (NICE, April 2020)
Read MoreREAD: CDC - Weekly Report 69:44 (COVID-19)
/
(4 RC) - These findings suggest that transmission of SARS-CoV-2 within households is high, occurs quickly, and can originate from both children and adults. Prompt adoption of disease control measures, including self-isolating at home, appropriate self-quarantine of household contacts, and all household members wearing a mask in shared spaces, can reduce the probability of household transmission … (CDC, Nov. 2020)
Read MoreREAD: OSHA - Guidance on Preparing Workplaces for COVID-19
/
(3 RC) - Coronavirus Disease 2019 (COVID-19) is a respiratory disease caused by the SARS-CoV-2 virus. It has spread from China to many other countries around the world, including the United States. Depending on the severity of COVID-19’s international impacts, outbreak conditions—including those rising to the level of a pandemic—can affect...(OSHA, 2020)
Read MoreREAD: WHO - COVID-19 Investigation Protocol for Schools
/
(4 RC) - This protocol provides guidance for investigating transmission of SARS-CoV-2 in schools and other educational institutions. The protocol should be adapted and used locally, however the use of a standardized methodology enable results to be compared…(WHO, 2020)
Read MoreREAD: WHO - COVID-19 Infection Control in Healthcare Facilities
/
(3 RC) - WHO has developed the “Infection prevention and control health-care facility response for COVID-19” monitoring tool. This tool has been designed to assess infection prevention and control capacities to respond to COVID-19 in health facilities. This tool forms part of a wider suite of health service capacity assessment tools…(WHO, 2020)
Read MoreREAD: CDC - COVID-19 Infection Control Recommendations for Healthcare Personnel
/
(1 RC) - This document provides CDC recommendations for healthcare workers with respect to infection control concerns during the COVID-19 pandemic. This guidance is applicable to all U.S. settings where healthcare is delivered. This guidance is not intended for non-healthcare settings (e.g., restaurants) OR for persons outside of healthcare settings…(CDC, 2019)
Read MoreREAD: Mold Related Fact Sheets
/
(3 RC) - Research and recommendations from the CDC and other organizations related to mold remediation, mold, and other fungal diseases.
Read MoreREAD: Transmission of Clostridium Difficile
/
(1 RC) - This document from the HHS studies the relationship between hospital room square footage and the transmission of Clostridium Difficile.
Read MoreREAD: Hand Hygiene in Health-Care Settings
/
(4 RC) - This document details proper hand hygiene for the prevention of HAIs in health-care facilities.
Read MoreREAD: Prevention of Surgical Site Infection
/
(3 RC) - This document from the CDC offers guidance on the prevention of infection at surgical sites.
Read MoreREAD: Personal Protection Against Ebola for Health-Care Workers
/
(1 RC) - This document from the CDC details the correct procedures for protecting health-care workers who are dealing with patients infected with the ebola virus.
Read MoreREAD: CDC - Health-Care Related Pneumonia Part 2 of 2
/
(4 RC) - This document contains a CDC guide for the prevention of health-care related pneumonia.
Read MoreREAD: CDC - Health-Care Related Pneumonia Part 1 of 2
/
(4 RC) - This document contains a CDC guide for the prevention of health-care related pneumonia.
Read MoreREAD: Action Plan to Prevent HAIs Part 2 of 2
/
(4 RC) - This document from the HHS represents the key actions needed to prevent HAIs and the containment of dangerous infections.
Read MoreREAD: Action Plan to Prevent HAIs Part 1 of 2
/